---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-422437"
form_type: "8-K"
ticker: "CRBP"
cik: "0001595097"
company_name: "Corbus Pharmaceuticals Holdings, Inc."
filed_at: "2026-10-15T14:27:48+00:00"
generated_at: "2026-10-15T14:29:07.648026+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Corbus Pharmaceuticals updates investor presentation; no new financial or clinical data disclosed

## Summary
- Exhibit 99.1 is an updated corporate deck titled 'Connecting Innovation to Purpose,' dated October 15, 2026.
- The filing text discloses no financial results, trial data, guidance or deal terms, and no substantive content from the deck was included.
- Signed by CEO Yuval Cohen; Corbus (CRBP) common stock is listed on the Nasdaq Capital Market.
- Company headquarters listed as 500 River Ridge Drive, Norwood, Massachusetts.

## SEC filing metadata
- accession: 0001193125-26-422437
- form_type: 8-K
- ticker: CRBP
- cik: 0001595097
- company_name: Corbus Pharmaceuticals Holdings, Inc.
- filed_at: 2026-10-15T14:27:48+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595097/000119312526422437/0001193125-26-422437-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595097/000119312526422437/crbp-20261015.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-422437
- JSON: https://secwatch.observer/filing/0001193125-26-422437.json
- Plain text: https://secwatch.observer/filing/0001193125-26-422437.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.